GSK PLC-SPON ADR (GSK) Stock Earnings Estimates
NYSE:GSK • US37733W2044
57.07 USD
-1.22 (-2.09%)
At close: Mar 3, 2026
56.4709 USD
-0.6 (-1.05%)
After Hours: 3/3/2026, 8:16:18 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 30.328B 3.42% | 31.376B 3.46% | 32.667B 4.11% | 34.873B 6.75% | 36.574B 4.88% | 37.722B 3.14% | 39.274B 4.11% | 38.737B -1.37% | 38.575B -0.42% | 36.874B -4.41% | 36.66B -0.58% | |
| EBITDA YoY % growth | 10.598B 0.53% | 10.688B 0.85% | 12.753B 19.32% | 11.902B -6.67% | 12.57B 5.61% | 12.942B 2.96% | 13.442B 3.86% | 13.39B -0.39% | 12.574B -6.09% | 11.323B -9.95% | 10.966B -3.15% | |
| EBIT YoY % growth | 8.304B -1.08% | 8.137B -2.01% | 8.975B 10.30% | 10.042B 11.89% | 10.77B 7.25% | 11.051B 2.61% | 12.72B 15.10% | 12.147B -4.50% | 10.933B -9.99% | 9.776B -10.58% | 7.091B -27.47% | |
| Operating Margin | 27.38% | 25.93% | 27.47% | 28.80% | 29.45% | 29.30% | 32.39% | 31.36% | 28.34% | 26.51% | 19.34% | |
| EPS YoY % growth | 3.16 4.85% | 3.25 2.77% | 3.50 7.84% | 3.81 8.81% | 4.14 8.58% | 4.64 12.30% | 4.54 -2.28% | 4.47 -1.58% | 4.02 -10.09% | 3.61 -10.07% | 3.13 -13.33% |
All data in GBP
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.90 -1.37% | 0.95 0.55% | 1.18 5.71% | 0.48 -7.91% |
| Revenue Q2Q % growth | 7.886B 4.92% | 8.55B 7.06% | 9.234B 8.04% | 8.698B 0.93% |
| EBITDA Q2Q % growth | 2.91B -7.24% | 3.093B -30.01% | N/A | N/A |
| EBIT Q2Q % growth | 2.527B 9.20% | 2.676B 9.81% | 3.141B 12.70% | 1.84B 28.04% |
All data in GBP
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 0.52 9.91% | 0.48 | 0.04 | 8.69% |
| Q3 2025 Q2Q % growth | 1.12 10.66% | 0.99 | 0.13 | 12.80% |
| Q2 2025 Q2Q % growth | 0.95 7.14% | 0.88 | 0.07 | 7.67% |
| Q1 2025 Q2Q % growth | 0.91 4.18% | 0.83 | 0.08 | 9.85% |
| Q4 2024 Q2Q % growth | 0.47 -19.72% | 0.40 | 0.07 | 18.46% |
| Q3 2024 Q2Q % growth | 1.01 -1.39% | 0.91 | 0.10 | 10.89% |
| Q2 2024 Q2Q % growth | 0.88 11.86% | 0.80 | 0.09 | 11.14% |
| Q1 2024 Q2Q % growth | 0.88 16.49% | 0.76 | 0.11 | 14.88% |
| Q4 2023 Q2Q % growth | 0.59 12.02% | 0.60 | -0.01 | -1.98% |
| Q3 2023 Q2Q % growth | 1.03 7.46% | 0.97 | 0.05 | 5.56% |
| Q2 2023 Q2Q % growth | 0.79 12.14% | 0.73 | 0.06 | 7.52% |
| Q1 2023 Q2Q % growth | 0.75 -8.92% | 0.69 | 0.06 | 8.62% |
| Q4 2022 Q2Q % growth | 0.53 -19.38% | 0.46 | 0.06 | 13.62% |
| Q3 2022 Q2Q % growth | 0.95 2.51% | 0.83 | 0.12 | 14.45% |
| Q2 2022 Q2Q % growth | 0.70 -1.49% | 0.60 | 0.10 | 16.49% |
| Q1 2022 Q2Q % growth | 0.83 41.92% | 0.79 | 0.04 | 4.62% |
| Q4 2021 Q2Q % growth | 0.65 9.87% | 0.64 | 0.01 | 1.36% |
| Q3 2021 Q2Q % growth | 0.93 2.81% | 0.76 | 0.17 | 22.51% |
| Q2 2021 Q2Q % growth | 0.72 46.35% | 0.53 | 0.19 | 35.82% |
| Q1 2021 Q2Q % growth | 0.58 -38.77% | 0.56 | 0.02 | 3.70% |
| Q4 2020 Q2Q % growth | 0.59 | 0.61 | -0.02 | -2.81% |
| Q3 2020 Q2Q % growth | 0.91 | 0.80 | 0.10 | 13.09% |
| Q2 2020 Q2Q % growth | 0.49 | 0.53 | -0.04 | -8.23% |
| Q1 2020 Q2Q % growth | 0.95 | 0.81 | 0.15 | 18.15% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 8.618B 6.17% | 8.726B | -108M | -1.24% |
| Q3 2025 Q2Q % growth | 8.547B 6.68% | 8.571B | -24M | -0.28% |
| Q2 2025 Q2Q % growth | 7.986B 1.29% | 7.989B | -3M | -0.04% |
| Q1 2025 Q2Q % growth | 7.516B 2.08% | 7.638B | -122M | -1.60% |
| Q4 2024 Q2Q % growth | 8.117B 0.81% | 7.983B | 134M | 1.68% |
| Q3 2024 Q2Q % growth | 8.012B -1.66% | 8.298B | -286M | -3.45% |
| Q2 2024 Q2Q % growth | 7.884B 9.84% | 7.695B | 189M | 2.46% |
| Q1 2024 Q2Q % growth | 7.363B 5.93% | 7.279B | 84M | 1.15% |
| Q4 2023 Q2Q % growth | 8.052B 9.16% | 7.513B | 539M | 7.17% |
| Q3 2023 Q2Q % growth | 8.147B 4.06% | 7.964B | 183M | 2.30% |
| Q2 2023 Q2Q % growth | 7.178B 3.59% | 7.032B | 146M | 2.08% |
| Q1 2023 Q2Q % growth | 6.951B -3.32% | 6.634B | 317M | 4.78% |
| Q4 2022 Q2Q % growth | 7.376B 4.24% | 7.563B | -187M | -2.47% |
| Q3 2022 Q2Q % growth | 7.829B 18.14% | 7.555B | 274M | 3.63% |
| Q2 2022 Q2Q % growth | 6.929B 18.69% | 6.702B | 227M | 3.39% |
| Q1 2022 Q2Q % growth | 7.19B -3.07% | 9.265B | -2.075B | -22.40% |
| Q4 2021 Q2Q % growth | 7.076B -19.03% | 9.782B | -2.706B | -27.66% |
| Q3 2021 Q2Q % growth | 6.627B -23.35% | 8.986B | -2.359B | -26.25% |
| Q2 2021 Q2Q % growth | 5.838B -23.43% | 7.785B | -1.947B | -25.01% |
| Q1 2021 Q2Q % growth | 7.418B -18.39% | 8.12B | -702M | -8.65% |
| Q4 2020 Q2Q % growth | 8.739B | 9.001B | -262M | -2.91% |
| Q3 2020 Q2Q % growth | 8.646B | 9.034B | -388M | -4.29% |
| Q2 2020 Q2Q % growth | 7.624B | 7.953B | -329M | -4.14% |
| Q1 2020 Q2Q % growth | 9.09B | 8.949B | 141M | 1.58% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.11% | -5.81% | 0.13% | 0.57% |
| Revenue | -0.83% | -1.31% | -0.9% | -0.43% |